1946. In Vitro Activity of Ceftobiprole against Staphylococcus aureus Bacteremia Isolates from the United States (2018–2020)

BACKGROUND: Ceftobiprole (BPR) is an advanced-generation cephalosporin approved in Europe and many non-European countries for the treatment of community-acquired pneumonia and non–ventilator-associated hospital-acquired pneumonia in adults. A Phase 3 clinical trial (NCT03138733) was recently complet...

Descripción completa

Detalles Bibliográficos
Autores principales: Duncan, Leonard R, Castanheira, Mariana, Smart, Jennifer, Jones, Mark E, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677211/
http://dx.doi.org/10.1093/ofid/ofad500.100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677211/
http://dx.doi.org/10.1093/ofid/ofad500.100

Ejemplares similares